The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Bronchospasm - Wheezing - Asthma
Publications
Dipyridamole (Persantin)-induced asthma during thallium stress testing.
The Journal of allergy and clinical immunology. 2005;115(1):203-4
Respiratory arrest during dipyridamole stress testing.
Postgraduate medical journal. 1997;73(859):301-2
Dipyridamole-thallium stress testing: a local community hospital experience.
Maryland medical journal (Baltimore, Md. : 1985). 1993;42(7):663-7
The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Intravenous Dipyridamole Thallium Imaging Study Group.
Circulation. 1990;81(4):1205-9